vs
Blue Bird Corp（BLBD）与Ultragenyx Pharmaceutical Inc.（RARE）财务数据对比。点击上方公司名可切换其他公司
Blue Bird Corp的季度营收约是Ultragenyx Pharmaceutical Inc.的1.6倍（$333.1M vs $207.3M），Blue Bird Corp净利率更高（9.2% vs -62.0%，领先71.3%），Ultragenyx Pharmaceutical Inc.同比增速更快（25.9% vs 6.1%），Blue Bird Corp自由现金流更多（$31.1M vs $-100.8M），过去两年Ultragenyx Pharmaceutical Inc.的营收复合增速更高（38.0% vs -1.9%）
蓝鸟公司是美国知名客车制造企业，总部位于佐治亚州福特瓦利，主打产品为校车，同时业务覆盖多种客车类型的生产，包括城市公交、旅居房车，以及移动图书馆、流动警务指挥中心等特种车辆。
Ultragenyx Pharmaceutical Inc.是一家总部位于美国的生物制药企业，专注于研发罕见病和超罕见遗传病的创新治疗方案，这类疾病目前大多无获批疗法，存在大量未被满足的临床需求。公司覆盖生物制剂、小分子药物、基因疗法、反义寡核苷酸及mRNA等多种药物技术平台，研发管线涵盖骨骼、内分泌、代谢、肌肉及中枢神经系统疾病领域。
BLBD vs RARE — 直观对比
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $333.1M | $207.3M |
| 净利润 | $30.8M | $-128.6M |
| 毛利率 | 21.4% | — |
| 营业利润率 | 11.3% | -54.7% |
| 净利率 | 9.2% | -62.0% |
| 营收同比 | 6.1% | 25.9% |
| 净利润同比 | 7.1% | 3.5% |
| 每股收益（稀释后） | $0.94 | $-1.28 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
| Q4 25 | $333.1M | $207.3M | ||
| Q3 25 | $409.4M | $159.9M | ||
| Q2 25 | $398.0M | $166.5M | ||
| Q1 25 | $358.9M | $139.3M | ||
| Q4 24 | $313.9M | $164.6M | ||
| Q3 24 | $350.2M | $139.5M | ||
| Q2 24 | $333.4M | $147.0M | ||
| Q1 24 | $345.9M | $108.8M |
| Q4 25 | $30.8M | $-128.6M | ||
| Q3 25 | $36.5M | $-180.4M | ||
| Q2 25 | $36.5M | $-115.0M | ||
| Q1 25 | $26.0M | $-151.1M | ||
| Q4 24 | $28.7M | $-133.2M | ||
| Q3 24 | $24.7M | $-133.5M | ||
| Q2 24 | $28.7M | $-131.6M | ||
| Q1 24 | $26.0M | $-170.7M |
| Q4 25 | 21.4% | — | ||
| Q3 25 | 21.1% | — | ||
| Q2 25 | 21.6% | — | ||
| Q1 25 | 19.7% | — | ||
| Q4 24 | 19.2% | — | ||
| Q3 24 | 17.0% | — | ||
| Q2 24 | 20.8% | — | ||
| Q1 24 | 18.4% | — |
| Q4 25 | 11.3% | -54.7% | ||
| Q3 25 | 12.3% | -106.9% | ||
| Q2 25 | 12.6% | -64.8% | ||
| Q1 25 | 9.4% | -102.6% | ||
| Q4 24 | 10.5% | -74.3% | ||
| Q3 24 | 7.3% | -94.6% | ||
| Q2 24 | 11.9% | -79.1% | ||
| Q1 24 | 10.4% | -151.9% |
| Q4 25 | 9.2% | -62.0% | ||
| Q3 25 | 8.9% | -112.8% | ||
| Q2 25 | 9.2% | -69.0% | ||
| Q1 25 | 7.3% | -108.5% | ||
| Q4 24 | 9.2% | -80.9% | ||
| Q3 24 | 7.0% | -95.7% | ||
| Q2 24 | 8.6% | -89.5% | ||
| Q1 24 | 7.5% | -156.8% |
| Q4 25 | $0.94 | $-1.28 | ||
| Q3 25 | $1.11 | $-1.81 | ||
| Q2 25 | $1.12 | $-1.17 | ||
| Q1 25 | $0.79 | $-1.57 | ||
| Q4 24 | $0.86 | $-1.34 | ||
| Q3 24 | $0.71 | $-1.40 | ||
| Q2 24 | $0.85 | $-1.52 | ||
| Q1 24 | $0.79 | $-2.03 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $241.7M | $421.0M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $271.4M | $-80.0M |
| 总资产 | $642.3M | $1.5B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
| Q4 25 | $241.7M | $421.0M | ||
| Q3 25 | $229.3M | $202.5M | ||
| Q2 25 | $173.1M | $176.3M | ||
| Q1 25 | $130.7M | $127.1M | ||
| Q4 24 | $136.1M | $174.0M | ||
| Q3 24 | $127.7M | $150.6M | ||
| Q2 24 | $88.4M | $480.7M | ||
| Q1 24 | $93.1M | $112.3M |
| Q4 25 | $271.4M | $-80.0M | ||
| Q3 25 | $255.4M | $9.2M | ||
| Q2 25 | $221.8M | $151.3M | ||
| Q1 25 | $190.4M | $144.2M | ||
| Q4 24 | $179.7M | $255.0M | ||
| Q3 24 | $159.6M | $346.8M | ||
| Q2 24 | $137.3M | $432.4M | ||
| Q1 24 | $105.8M | $140.3M |
| Q4 25 | $642.3M | $1.5B | ||
| Q3 25 | $625.3M | $1.2B | ||
| Q2 25 | $575.5M | $1.3B | ||
| Q1 25 | $543.7M | $1.3B | ||
| Q4 24 | $535.2M | $1.5B | ||
| Q3 24 | $524.9M | $1.5B | ||
| Q2 24 | $468.1M | $1.6B | ||
| Q1 24 | $456.5M | $1.3B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $36.6M | $-99.8M |
| 自由现金流经营现金流 - 资本支出 | $31.1M | $-100.8M |
| 自由现金流率自由现金流/营收 | 9.3% | -48.6% |
| 资本支出强度资本支出/营收 | 1.6% | 0.5% |
| 现金转化率经营现金流/净利润 | 1.19× | — |
| 过去12个月自由现金流最近4个季度 | $162.6M | $-472.0M |
8季度趋势，按日历期对齐
| Q4 25 | $36.6M | $-99.8M | ||
| Q3 25 | $65.1M | $-91.4M | ||
| Q2 25 | $56.9M | $-108.3M | ||
| Q1 25 | $27.8M | $-166.5M | ||
| Q4 24 | $26.4M | $-79.3M | ||
| Q3 24 | $55.4M | $-67.0M | ||
| Q2 24 | $989.0K | $-77.0M | ||
| Q1 24 | $54.6M | $-190.7M |
| Q4 25 | $31.1M | $-100.8M | ||
| Q3 25 | $60.5M | $-92.7M | ||
| Q2 25 | $52.3M | $-110.7M | ||
| Q1 25 | $18.7M | $-167.8M | ||
| Q4 24 | $21.8M | $-79.5M | ||
| Q3 24 | $50.2M | $-68.6M | ||
| Q2 24 | $-3.5M | $-79.0M | ||
| Q1 24 | $51.8M | $-193.9M |
| Q4 25 | 9.3% | -48.6% | ||
| Q3 25 | 14.8% | -58.0% | ||
| Q2 25 | 13.1% | -66.5% | ||
| Q1 25 | 5.2% | -120.5% | ||
| Q4 24 | 7.0% | -48.3% | ||
| Q3 24 | 14.3% | -49.2% | ||
| Q2 24 | -1.1% | -53.7% | ||
| Q1 24 | 15.0% | -178.2% |
| Q4 25 | 1.6% | 0.5% | ||
| Q3 25 | 1.1% | 0.8% | ||
| Q2 25 | 1.2% | 1.5% | ||
| Q1 25 | 2.5% | 1.0% | ||
| Q4 24 | 1.5% | 0.1% | ||
| Q3 24 | 1.5% | 1.2% | ||
| Q2 24 | 1.3% | 1.4% | ||
| Q1 24 | 0.8% | 3.0% |
| Q4 25 | 1.19× | — | ||
| Q3 25 | 1.78× | — | ||
| Q2 25 | 1.56× | — | ||
| Q1 25 | 1.07× | — | ||
| Q4 24 | 0.92× | — | ||
| Q3 24 | 2.24× | — | ||
| Q2 24 | 0.03× | — | ||
| Q1 24 | 2.10× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
BLBD
| Alternative Fuel Buses | $151.4M | 45% |
| Diesel Buses | $144.9M | 43% |
| Parts | $24.8M | 7% |
| Other | $12.1M | 4% |
RARE
| Royalty | $105.6M | 51% |
| Products | $101.7M | 49% |
